HomeCancerResearch

Research

ODAC vote will probably result in three-arm and four-arm designs–and pragmatic trials–for perioperative indications – The Most cancers Letter

ODAC vote will probably result in three-arm and four-arm designs–and pragmatic trials–for perioperative indications  The Most cancers Letter

Tweaking the prevailing programs isn’t the reply to drug shortages

To the editor, Within the July 19 article “Platinum medicine are off the scarcity record, however the underlying downside is unsolved,” FDA Commissioner Robert...

Rakovina Therapeutics Secures $2 Million for Most cancers Analysis

Rakovina Therapeutics Inc (TSE:RKV) has launched an replace. Rakovina Therapeutics Inc. has efficiently accomplished an oversubscribed non-public placement, elevating $2 million to advance its...

Hot Topics